GAROFALO HEALTH CARE SPA (GHC.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:GHC - IT0005345233 - Common Stock
5.55 EUR
-0.02 (-0.36%)
GHC gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 28 industry peers in the Health Care Providers & Services industry. GHC has only an average score on both its financial health and profitability. GHC is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
GHC had positive earnings in the past year.
In the past year GHC had a positive cash flow from operations.
In the past 5 years GHC has always been profitable.
In the past 5 years GHC always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of GHC (3.66%) is better than 64.29% of its industry peers.
GHC's Return On Equity of 9.57% is in line compared to the rest of the industry. GHC outperforms 50.00% of its industry peers.
GHC has a Return On Invested Capital of 6.52%. This is in the better half of the industry: GHC outperforms 64.29% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GHC is below the industry average of 6.91%.
The 3 year average ROIC (4.41%) for GHC is below the current ROIC(6.52%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.66% | ||
| ROE | 9.57% | ||
| ROIC | 6.52% |
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
1.3 Margins
GHC has a better Profit Margin (4.62%) than 71.43% of its industry peers.
GHC's Profit Margin has declined in the last couple of years.
The Operating Margin of GHC (9.37%) is better than 75.00% of its industry peers.
In the last couple of years the Operating Margin of GHC has declined.
The Gross Margin of GHC (44.90%) is better than 67.86% of its industry peers.
GHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.37% | ||
| PM (TTM) | 4.62% | ||
| GM | 44.9% |
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
2. Health
2.1 Basic Checks
GHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, GHC has about the same amount of shares outstanding.
Compared to 5 years ago, GHC has more shares outstanding
GHC has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.97 indicates that GHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.97, GHC is in line with its industry, outperforming 50.00% of the companies in the same industry.
GHC has a debt to FCF ratio of 70.49. This is a negative value and a sign of low solvency as GHC would need 70.49 years to pay back of all of its debts.
GHC has a Debt to FCF ratio of 70.49. This is in the lower half of the industry: GHC underperforms 71.43% of its industry peers.
A Debt/Equity ratio of 0.67 indicates that GHC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.67, GHC is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 70.49 | ||
| Altman-Z | 1.97 |
ROIC/WACC1
WACC6.53%
2.3 Liquidity
GHC has a Current Ratio of 1.16. This is a normal value and indicates that GHC is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.16, GHC perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
GHC has a Quick Ratio of 1.12. This is a normal value and indicates that GHC is financially healthy and should not expect problems in meeting its short term obligations.
GHC has a Quick ratio of 1.12. This is in the better half of the industry: GHC outperforms 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
GHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.11%.
GHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.81% yearly.
GHC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.44%.
The Revenue has been growing by 18.92% on average over the past years. This is quite good.
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
3.2 Future
GHC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.47% yearly.
GHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.51% yearly.
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 15.42 indicates a correct valuation of GHC.
Based on the Price/Earnings ratio, GHC is valued a bit cheaper than the industry average as 67.86% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of GHC to the average of the S&P500 Index (26.84), we can say GHC is valued slightly cheaper.
The Price/Forward Earnings ratio is 17.17, which indicates a rather expensive current valuation of GHC.
GHC's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.40. GHC is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.42 | ||
| Fwd PE | 17.17 |
4.2 Price Multiples
75.00% of the companies in the same industry are more expensive than GHC, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GHC indicates a slightly more expensive valuation: GHC is more expensive than 71.43% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 154.13 | ||
| EV/EBITDA | 7.6 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of GHC may justify a higher PE ratio.
PEG (NY)4.47
PEG (5Y)1.75
EPS Next 2Y5.05%
EPS Next 3Y6.47%
5. Dividend
5.1 Amount
GHC has a Yearly Dividend Yield of 1.55%.
GHC's Dividend Yield is a higher than the industry average which is at 1.47.
GHC's Dividend Yield is slightly below the S&P500 average, which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.55% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y5.05%
EPS Next 3Y6.47%
BIT:GHC (12/30/2025, 12:22:46 PM)
5.55
-0.02 (-0.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners11.81%
Inst Owner ChangeN/A
Ins Owners63%
Ins Owner ChangeN/A
Market Cap500.61M
Revenue(TTM)690.85M
Net Income(TTM)31.91M
Analysts84
Price Target6.73 (21.26%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.55% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.42 | ||
| Fwd PE | 17.17 | ||
| P/S | 0.72 | ||
| P/FCF | 154.13 | ||
| P/OCF | 17.92 | ||
| P/B | 1.5 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.6 |
EPS(TTM)0.36
EY6.49%
EPS(NY)0.32
Fwd EY5.82%
FCF(TTM)0.04
FCFY0.65%
OCF(TTM)0.31
OCFY5.58%
SpS7.66
BVpS3.7
TBVpS-0.44
PEG (NY)4.47
PEG (5Y)1.75
Graham Number5.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.66% | ||
| ROE | 9.57% | ||
| ROCE | 9.13% | ||
| ROIC | 6.52% | ||
| ROICexc | 6.77% | ||
| ROICexgc | 14.86% | ||
| OM | 9.37% | ||
| PM (TTM) | 4.62% | ||
| GM | 44.9% | ||
| FCFM | 0.47% |
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
ROICexc(3y)4.63%
ROICexc(5y)4.13%
ROICexgc(3y)10.78%
ROICexgc(5y)9.37%
ROCE(3y)6.5%
ROCE(5y)5.8%
ROICexgc growth 3Y7.97%
ROICexgc growth 5Y2.8%
ROICexc growth 3Y6.71%
ROICexc growth 5Y0.74%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
F-Score5
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 70.49 | ||
| Debt/EBITDA | 2.47 | ||
| Cap/Depr | 94.13% | ||
| Cap/Sales | 3.57% | ||
| Interest Coverage | 6.62 | ||
| Cash Conversion | 30.7% | ||
| Profit Quality | 10.18% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 1.97 |
F-Score5
WACC6.53%
ROIC/WACC1
Cap/Depr(3y)82.25%
Cap/Depr(5y)102.09%
Cap/Sales(3y)4.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)118.21%
Profit Quality(5y)101.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
EPS Next Y3.45%
EPS Next 2Y5.05%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
EBIT growth 1Y-8.88%
EBIT growth 3Y18.26%
EBIT growth 5Y14.91%
EBIT Next Year68.09%
EBIT Next 3Y22.98%
EBIT Next 5Y16.09%
FCF growth 1Y-88.34%
FCF growth 3Y4.79%
FCF growth 5Y6.69%
OCF growth 1Y-35.2%
OCF growth 3Y-1.23%
OCF growth 5Y13.09%
GAROFALO HEALTH CARE SPA / GHC.MI FAQ
Can you provide the ChartMill fundamental rating for GAROFALO HEALTH CARE SPA?
ChartMill assigns a fundamental rating of 4 / 10 to GHC.MI.
Can you provide the valuation status for GAROFALO HEALTH CARE SPA?
ChartMill assigns a valuation rating of 3 / 10 to GAROFALO HEALTH CARE SPA (GHC.MI). This can be considered as Overvalued.
Can you provide the profitability details for GAROFALO HEALTH CARE SPA?
GAROFALO HEALTH CARE SPA (GHC.MI) has a profitability rating of 6 / 10.
What are the PE and PB ratios of GAROFALO HEALTH CARE SPA (GHC.MI) stock?
The Price/Earnings (PE) ratio for GAROFALO HEALTH CARE SPA (GHC.MI) is 15.42 and the Price/Book (PB) ratio is 1.5.
How financially healthy is GAROFALO HEALTH CARE SPA?
The financial health rating of GAROFALO HEALTH CARE SPA (GHC.MI) is 4 / 10.